29.09.2022 - SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) - Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin ...